The current advances in research into the regulation of TGF-β signaling and particularly the Smad3-dependent noncoding RNAs have improved our understanding of the molecular mechanisms of renal inflammation and fibrosis in kidney diseases. Here, SMAD3 is linked to kidney disorder.